Credo stock slips as chip ETFs jump; Form 144 filing draws focus

Credo stock slips as chip ETFs jump; Form 144 filing draws focus

NEW YORK, Jan 3, 2026, 17:18 ET — Market closed

  • Credo Technology shares closed down 0.5% on Friday, lagging a sharp rally in semiconductor ETFs.
  • The company’s investor relations site listed a Form 144 filing dated Jan. 2, a notice that can precede insider stock sales.
  • Investors are watching next week’s U.S. payrolls report and the company’s next results window penciled in for early March.

Credo Technology Group Holding Ltd shares ended Friday down 0.47% at $143.22, even as broader semiconductor ETFs rose strongly.

The underperformance matters now because Credo has become a closely watched play on high-speed data-center connectivity, a niche tied to spending on AI computing clusters. In that corner of the market, traders tend to react quickly to any signal that insiders may be reducing exposure. Business Wire

It also comes as chip stocks have been swinging with shifts in risk appetite, leaving little room for disappointments in high-multiple names. Credo’s market capitalization is about $32.5 billion, and the stock trades at a triple-digit price-to-earnings multiple based on trailing results, according to market data.

On Friday, Credo traded between roughly $141 and $152 and finished near the lower end of that range. About 5.8 million shares changed hands, according to Nasdaq data.

By contrast, the iShares Semiconductor ETF rose about 4.2% and the VanEck Semiconductor ETF gained about 3.7%. Among large-cap peers tied to data-center spending, Marvell Technology rose about 5.2%, Nvidia gained about 1.2% and Broadcom added about 0.4%, while Astera Labs jumped about 7.9%.

A key company-specific item in the past 48 hours was a Form 144 dated Jan. 2 listed on Credo’s investor relations website. Form 144 is a U.S. Securities and Exchange Commission notice of a proposed sale of securities under Rule 144, which governs resales of restricted or control securities.

A Form 144 does not guarantee a sale will occur, but it is often read by traders as a precursor to potential insider selling. Credo’s site did not provide additional context in the listing itself beyond describing it as a Form 144 filing.

Credo last reported quarterly results on Dec. 1, when it posted revenue of $268.0 million for its fiscal second quarter ended Nov. 1, along with GAAP net income of $82.6 million and an ending cash and short-term investment balance of $813.6 million, the company said. Business Wire

“In the second quarter Credo delivered revenue of $268.0 million,” CEO Bill Brennan said in that statement, adding that the results reflected “the continued build-out of the world’s largest AI training and inference clusters.” Business Wire

Credo sells connectivity products used in high-speed Ethernet and data infrastructure, including solutions built on serializer/deserializer (SerDes) and digital signal processor (DSP) technologies. Those components move data at very high rates inside and between servers, switches and optical modules. Business Wire

Before Monday’s open, investors will be watching whether the filing draws follow-through selling pressure after the weekend, and whether the chip sector’s strength holds. The next major macro test for growth stocks is the U.S. employment report due at 8:30 a.m. ET on Friday, Jan. 9, according to the U.S. Bureau of Labor Statistics schedule.

Beyond that, the next clear company catalyst is the next earnings update. The company has not confirmed a date, but third-party calendars such as Zacks have penciled in March 3, 2026.

Technically, traders are likely to keep an eye on Friday’s low near $141 as a near-term support area and the day’s high near $152 as a nearby resistance level, after the stock closed at $143.22.

For now, Credo’s setup is split: chip peers and semiconductor ETFs were broadly higher into the weekend, while Credo’s slight decline and the Form 144 notice kept the focus on positioning and insider-related signals rather than new product news.

Stock Market Today

  • Unilever valuation after pullback points to £53.37 fair value (undervalued)
    January 4, 2026, 8:43 PM EST. Unilever (LSE:ULVR) trades around £48.23 after a month of drift, with a track record of steady earnings growth underpinning cash generation. A recent analysis puts a fair value at about £53.37, suggesting the stock is undervalued versus consensus targets. The bull case rests on a shift toward premiumisation in Personal Care and Beauty & Wellbeing, plus bolt-on acquisitions that lift exposure to higher-margin categories and longer-term margins. The story blends buybacks with a gradual derating of multiples to reflect macro risks. Key downsides include intense competition and weaker emerging-market volumes that could erode pricing power. While the setup reads constructive, investors should weigh execution risk and the timing of earnings milestones when sizing the upside.
Bristol-Myers Squibb (BMY) stock fell Friday — here’s what investors are watching next
Previous Story

Bristol-Myers Squibb (BMY) stock fell Friday — here’s what investors are watching next

Dow, S&P 500 snap losing streak as chip and AI stocks kick off 2026 with a rally
Next Story

Dow, S&P 500 snap losing streak as chip and AI stocks kick off 2026 with a rally

Go toTop